PAOLINI PAOLETTI, FEDERICO

PAOLINI PAOLETTI, FEDERICO  

DIPARTIMENTO DI MEDICINA E CHIRURGIA  

Mostra records
Risultati 1 - 20 di 23 (tempo di esecuzione: 0.035 secondi).
Titolo Data di pubblicazione Autore(i) File
A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy Bodies 1-gen-2020 Bellomo, Giovanni; Paolini Paoletti, Federico; Chipi, Elena; Petricciuolo, Maya; Simoni, Simone; Tambasco, Nicola; Parnetti, Lucilla
Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers 1-gen-2022 Barba, L.; Paolini Paoletti, F.; Bellomo, G.; Gaetani, L.; Halbgebauer, S.; Oeckl, P.; Otto, M.; Parnetti, L.
Blood biomarkers may distinguish among dementia disorders 1-gen-2022 Parnetti, Lucilla; Paolini Paoletti, Federico; Gaetani, Lorenzo
Cerebrospinal fluid levels of proenkephalin and prodynorphin are differentially altered in Huntington's and Parkinson's disease 1-gen-2022 Barschke, Peggy; Abu-Rumeileh, Samir; Al Shweiki, M H D Rami; Barba, Lorenzo; Paolini Paoletti, Federico; Oeckl, Patrick; Steinacker, Petra; Halbgebauer, Steffen; Gaetani, Lorenzo; Lewerenz, Jan; Ludolph, Albert Christian; Landwehrmeyer, Georg Bernhard; Parnetti, Lucilla; Otto, Markus
Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's disease 1-gen-2022 Barba, Lorenzo; Abu Rumeileh, Samir; Bellomo, Giovanni; Paolini Paoletti, Federico; Halbgebauer, Steffen; Oeckl, Patrick; Steinacker, Petra; Massa, Federico; Gaetani, Lorenzo; Parnetti, Lucilla; Otto, Markus
The Challenge of Disease-Modifying Therapies in Parkinson's Disease: Role of CSF Biomarkers. 1-gen-2020 Paolini Paoletti, F; Gaetani, L; Parnetti, L
Changes of olfactory tract in Parkinson’s disease: a DTI tractography study 1-gen-2020 Nigro, P.; Chiappiniello, A.; Simoni, S.; Paolini Paoletti, F.; Cappelletti, G.; Chiarini, P.; Filidei, M.; Eusebi, P.; Guercini, G.; Santangelo, V.; Tarducci, R.; Calabresi, P.; Parnetti, L.; Tambasco, N.
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment 1-gen-2020 Gaetani, L.; Paolini Paoletti, F.; Bellomo, G.; Mancini, A.; Simoni, S.; Di Filippo, M.; Parnetti, L.
Drug-induced Creutzfeldt-Jakob disease-like syndrome: Early CSF analysis as useful tool for differential diagnosis 1-gen-2018 Paoletti, Federico Paolini; Di Gregorio, Maria; Calabresi, Paolo; Parnetti, Lucilla
High performance liquid chromatography determination of L-glutamate, L-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients affected by Alzheimer's disease 1-gen-2021 Nuzzo, Tommaso; Mancini, Andrea; Miroballo, Mattia; Casamassa, Alessia; Di Maio, Anna; Donati, Giorgia; Sansone, Giulia; Gaetani, Lorenzo; PAOLINI PAOLETTI, Federico; Isidori, Andrea; Calabresi, Paolo; Errico, Francesco; Parnetti, Lucilla; Usiello, Alessandro
Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson's Disease: Pulsatile versus Continuous Dopaminergic Stimulation 1-gen-2020 Simoni, Simone; Paoletti, Federico Paolini; Eusebi, Paolo; Cappelletti, Giulia; Filidei, Marta; Brahimi, Elona; Nigro, Pasquale; Santangelo, Valerio; Parnetti, Lucilla; Calabresi, Paolo; Tambasco, Nicola
Levodopa treatment in Parkinson's disease: earlier or later? 1-gen-2019 Paolini Paoletti, Federico; Tambasco, Nicola; Parnetti, Lucilla
Levodopa-responsive breathing discomfort in Parkinson’s disease patients 1-gen-2018 Tambasco, Nicola; Murgia, Nicola; Nigro, Pasquale; PAOLINI PAOLETTI, Federico; Romoli, Michele; Brahimi, Elona; Filidei, Marta; Simoni, Simone; Muzi, Giacomo; Calabresi, Paolo
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: Do fresh vs frozen samples differ? 1-gen-2020 Bellomo, G.; Cataldi, S.; Paciotti, S.; Paolini Paoletti, F.; Chiasserini, D.; Parnetti, L.
Molecular profiling in Parkinsonian syndromes: CSF biomarkers 1-gen-2020 Paolini Paoletti, F.; Gaetani, L.; Parnetti, L.
PEG-J replacement for duodenal levodopa infusion in Parkinson's disease patients: a retrospective study 1-gen-2022 Simoni, Simone; Nigro, Pasquale; Filidei, Marta; Cappelletti, Giulia; Paolini Paoletti, Federico; Castellani, Danilo; Gaggiotti, Mirko; Parnetti, Lucilla; Tambasco, Nicola
Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer's Disease: ELISA Development and Clinical Validation 1-gen-2022 Wojdała, Anna Lidia; Chiasserini, Davide; Bellomo, Giovanni; Paciotti, Silvia; Gaetani, Lorenzo; Paoletti, Federico Paolini; Parnetti, Lucilla
Risk factors of levodopa-induced dyskinesia in Parkinson's disease: results from the PPMI cohort 1-gen-2018 Eusebi, Paolo; Romoli, Michele; Paoletti, Federico Paolini; Tambasco, Nicola; Calabresi, Paolo; Parnetti, Lucilla
Specific Cerebrospinal Fluid SerpinA1 Isoform Pattern in Alzheimer's Disease 1-gen-2022 Barba, Lorenzo; Halbgebauer, Steffen; Paolini Paoletti, Federico; Bellomo, Giovanni; Abu-Rumeileh, Samir; Steinacker, Petra; Massa, Federico; Parnetti, Lucilla; Otto, Markus
Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study 1-gen-2019 Cardaioli, G.; Ripandelli, F.; Paolini Paoletti, F.; Nigro, P.; Simoni, S.; Brahimi, E.; Romoli, M.; Filidei, M.; Eusebi, P.; Calabresi, P.; Tambasco, N.